Shanghai No.1 Pharmacy Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	329.09	322.59	436.42	400.03	504.93	262.28
Short-Term Investments	42.97	98.04	85.62	66.29	40	-
Trading Asset Securities	29.28	1.03	15.38	30.15	220.29	-
Cash & Short-Term Investments	401.33	421.67	537.41	496.47	765.22	262.28
Cash Growth	-19.48%	-21.54%	8.25%	-35.12%	191.75%	-48.51%
Accounts Receivable	199.83	189.88	190.15	247.57	238	133.56
Other Receivables	55.57	46.97	30.4	23.31	27.1	31.32
Receivables	255.39	236.85	220.55	270.88	265.1	164.87
Inventory	362.03	354.94	336.32	332.23	334.75	214.5
Prepaid Expenses	0	7.15	9.39	3.52	0.78	0.44
Other Current Assets	28.92	36.42	23.33	14.13	31.29	20.59
Total Current Assets	1,048	1,057	1,127	1,117	1,397	662.69
Property, Plant & Equipment	222.72	253.56	260.88	215.36	181.09	167.98
Long-Term Investments	295.65	358.86	342.74	322.45	252.47	184.14
Other Intangible Assets	35.58	36.46	38.93	41.67	43.83	46.33
Long-Term Deferred Tax Assets	29.74	26.76	24.35	26.39	35.99	12.07
Long-Term Deferred Charges	22.52	24.57	20.58	16.28	14.43	9.28
Other Long-Term Assets	245.35	264.09	165.58	123.78	114.15	251.97
Total Assets	1,899	2,021	1,980	1,863	2,039	1,334

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	483.32	454.1	384.14	398.59	363.69	314.8
Accrued Expenses	4.25	24.35	26.51	27.09	32.57	15.02
Short-Term Debt	-	49.9	95.58	101.05	320.28	-
Current Portion of Leases	58.65	63.48	63.98	58.34	49.05	38.94
Current Income Taxes Payable	5.72	1.26	0.9	10.27	37.33	5.93
Current Unearned Revenue	5.07	3.55	5.36	5.71	25.53	2.71
Other Current Liabilities	69.04	69.85	71.68	75.74	97.91	66.64
Total Current Liabilities	626.05	666.49	648.15	676.79	926.37	444.04
Long-Term Leases	82.86	107.82	115.56	107.24	88.33	63.08
Long-Term Unearned Revenue	11.27	11.5	11.97	12.44	11.3	11.68
Pension & Post-Retirement Benefits	2.37	2.39	2.5	2.42	-	-
Long-Term Deferred Tax Liabilities	46.09	62.25	57.48	55.83	54.34	37.34
Other Long-Term Liabilities	-	-	-	-	0.07	0.4
Total Liabilities	768.65	850.46	835.66	854.72	1,080	556.54

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	223.09	223.09	223.09	223.09	223.09	223.09
Additional Paid-In Capital	65.53	65.53	65.53	65.19	65.19	65.19
Retained Earnings	697.42	688.65	679.98	544.95	499.18	371.24
Comprehensive Income & Other	134.64	184.02	167.01	168.22	164.22	111.4
Total Common Equity	1,121	1,161	1,136	1,001	951.67	770.92
Minority Interest	9.9	9.58	8.79	7.01	7.01	7.01
Shareholders' Equity	1,131	1,171	1,144	1,008	958.68	777.92
Total Liabilities & Equity	1,899	2,021	1,980	1,863	2,039	1,334

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	141.51	221.21	275.12	266.63	457.67	102.03
Net Cash (Debt)	259.82	200.46	262.29	229.83	307.55	160.26
Net Cash Growth	-12.25%	-23.57%	14.12%	-25.27%	91.91%	-51.34%
Net Cash Per Share	1.17	0.90	1.17	1.03	1.37	0.71
Filing Date Shares Outstanding	223.09	223.09	223.09	223.09	223.09	223.09
Total Common Shares Outstanding	223.09	223.09	223.09	223.09	223.09	223.09
Working Capital	421.62	390.53	478.85	440.44	470.77	218.65
Book Value Per Share	5.02	5.21	5.09	4.49	4.27	3.46
Tangible Book Value	1,085	1,125	1,097	959.77	907.85	724.58
Tangible Book Value Per Share	4.86	5.04	4.92	4.30	4.07	3.25
Buildings	101.59	101.59	105.19	89.34	94.76	94.76
Machinery	27.4	27.36	26.96	26.52	26	26.32
Construction In Progress	7.59	7.78	5.74	1.74	1.43	2.24